The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what are the biggest Canadian pharma stocks? Many successful Canadian drug companies are in the late stages of clinical trials, and some have also have brought pharmaceutical products to market or set up partnerships to develop products, both at home and globally. According to data compiled by the Canadian government, the country’s pharma companies are involved in research and development to bring new or improved patented therapies to market, and are also developing generic versions of bio-equivalent drugs whose patents have expired. Additionally, gene and cell therapies and nanomedicines are emerging fields in the Canadian pharmaceutical market. Read on for a look at the five biggest Canadian pharma stocks by market cap; TSX- and TSXV-listed companies were considered, but only firms on the TSX were large enough…
